Human Umbilical Cord Tissue
As compared to the bone marrow and the cord blood, a Human umbilical cord tissue falls under the category of rich source of Mesenchymal stem cells. It is derived as the best suited cell for tissue regeneration which is due to the fact that tissue repairing function is highly active and efficient in case of the Mesenchymal stem cells. Stem cells are also well-suited for modulation in the immune system and reduction in inflammation of any kind which may persist.
Bone marrow is a rich source of CD34+ stem cells, although it is rich in stem cells of one kind it is a poor source of mesenchymal stem cells which are bone marrow-derived stem cells. These provide support for the issue of tissue regeneration with the help of revascularization properties and also the ability to support Mesenchymal stem cells all through the body.
Because we have three major adult stem cells sources at our disposal, including the ability to expand cells into larger numbers when indicated, we can select optimal stem cell combinations for each disease and, if necessary, each individual we treat.
Cord blood just like Bone Marrow is high on CD34+ stem cells, but lags being a good source of Mesenchymal stem cells. The stem cells provide a great strength and support for the case of tissue regeneration which takes place via revascularization of properties and the ability to support the Mesenchymal stem cells inside the body.
Most protocols utilize the cord blood which requires Human leukocyte antigen better known as HLA, trying to match the donor cells with that of the recipient’s.
Adipose (fat) Tissue
Adipose tissue is high on Mesenchymal stem cells (MSCs) and T-regulatory cells, this helps modulate the working and efficiency of immune system. Adipose or fat derived stem cells are effectively used in treatment of systemic autoimmune conditions along with inflammatory conditions. These also play a vital role in the regeneration of injured tissue.
Because we have found that the immune modulatory and anti-inflammatory properties of umbilical cord tissue-derived mesenchymal stem cells (HUCT-MSCs) are superior to those harvested from fat, we no longer employ fat-derived MSCs in our treatment protocols.